The lab automation market has emerged as a transformative force within the realm of scientific research and experimentation. This technological evolution involves the integration of advanced robotics, software solutions, and instrumentation to streamline and enhance laboratory processes. As researchers and industries strive for greater efficiency, accuracy, and reproducibility, lab automation has become a pivotal enabler in achieving these goals.
One of the key drivers behind the rapid adoption of lab automation is its ability to significantly boost efficiency and precision. Tedious and time-consuming tasks that were once performed manually can now be automated, freeing up valuable time for researchers to focus on more intellectually demanding activities. This not only accelerates the pace of research but also reduces the potential for human errors, ensuring the reliability of results.
Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-394
The lab automation market is expected to be worth US$ 2.1 billion in 2023. The lab automation market is expected to grow at a CAGR of 10.1% during the forecast period, reaching US$ 5.5 billion by 2033, owing to the increasing adoption of lab automation across various end-use verticals.
Research and Innovations Aid Market Growth
Pharmaceutical research is in constant demand, which protects the market. In the pharmaceutical and healthcare industries, automation is also a major trend right now. Even in emerging countries, both of these are assisting the market. In order to meet the unique needs of lab automation users, additional important companies are eager to offer products that are industry-specific.
Fertile Ground for Market Growth
To maintain the rapid product uptake, key players must work more on product development. This era is anticipated to be profitable for market growth due to factors like rising diagnostic rates internationally. Recent trends show that major businesses are combining their resources through mergers and acquisitions to strengthen their market positions.
Technological Innovations Emerge as an Integral Part of Market Growth
Long-term market potential for lab automation are predicted to result from end-user demand for high-end, sophisticated lab automation technologies. The development of lab robotics technology, which is still in its infancy, is one factor that is anticipated to support market expansion. For lab automation technology to be appealing to pharmaceutical and healthcare enterprises of various sizes, it must be exceedingly frictionless and effective.
Can Market Key Players Rise Above the Hurdles of High Cost?
Adoption and maintenance of lab automation equipment currently amount to considerable costs. Hence, small and medium enterprises tend to shy away from the adoption of lab automation tools. The major consumer base of key players currently consists of mega-corporations, that are willing to spend millions for high-end efficient lab automation systems. By developing affordable products, key players can easily break into the small and medium enterprises segment. Once the large organization segment reaches saturation, key players will naturally have to turn to smaller enterprises to sustain market growth.
Unlock exclusive insights with our expert analysts :
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-394
Recent Market Developments:
- In March 2022, Beckman Coulter Life Sciences introduced the CellMek SPS. The product enables seamless manual sample preparation. It has aided in easing data management bottlenecks in clinical flow cytometry. It is a fully automated sample preparation system (SPS) that would aid laboratories in vastly expanding their current production capabilities.
- In April 2022, Strateos Inc. launched an integrated solution for small molecule discovery programs that aid in automating the DMTA cycles.
- In March 2022, Biosero released the Green Button Go software suite in March 2022. It comes with advanced features to assist customers in yielding better control over laboratory systems.
- In March 2022, Thermo Fisher Scientific and Hamilton Company jointly launched an advanced product. It is their forensic laboratory-qualified automated nucleic acid extraction platform.
Leading companies operating in the lab automation market are Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, Transcriptic, Inc. among others.
Key Segments:
By Component Type:
- Devices
- Biochemistry Devices
- Molecular Devices
- Hematology Devices
- Immunology Devices
- Microbiology Devices
- Others
- Software
- Scheduling Software
- Momentum Integration Software
By Application:
- Life Sciences Research and Development
- Drug Discovery
- Diagnostics
By End User:
- Pharmaceutical Companies
- Hospitals and Diagnostic Centers
- Educational Institutions
- Contract Research Organizations (CROs)
- Research Institutes
Unlock Tailored Insights: Customize Your Report for Maximum Impact :
https://www.futuremarketinsights.com/customization-available/rep-gb-394
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
